A biotech startup based in Uruguay has successfully completed early-stage human trials for a first-in-class drug that targets fat cells to burn more calories, even while the body is at rest. Developed ...

The first human-tested weight-loss drug that burns calories through creatine-based heat generation, without reducing appetite, has successfully completed its Phase I trial.